STAT+: At AACR, a provocative use of CAR-T, Merck’s new thing and cancer’s geography problem
At AACR, a bold use of CAR-T raises hopes and provocative questions about its use in smoldering multiple myeloma.
health_news
STAT+: Former banker brought on to revitalize Pfizer’s strategy departs his post
Andrew Baum, a former Citi analyst, has left his role as Pfizer's executive vice president and chief strategy and innovation officer.
STAT+: In early trial, CAR-T results raise hope of preventing multiple myeloma in high-risk patients
A CAR-T trial shows promise in preventing smoldering multiple myeloma from becoming the real thing.
Weight Loss Medication Options in 2026
An authoritative look at current FDA-approved weight loss medications, their brands and results, and how obesity intersects with disability
STAT+: Finally cracking KRAS as a druggable target
The Breakthrough Prize winners, Trump's psychedelics executive order, and more biotech news from The Readout
STAT+: Pharmalittle: We’re reading about Trump boosting psychedelic treatment, the future for weight-loss drugs, and more
And more pharma news from the Pharmalot campus via the Pharmalittle newsletter
STAT+: PBMs warn Trump’s proposal to disclose drug prices is illegal
Pharma industry middlemen are pushing back on a major drug price transparency proposal.
STAT+: A controversy over research monkeys highlights ambiguity over health standards
A leading animal rights group is accusing Pfizer of running afoul of its own standards in the handling of research monkeys.
Peter Stetson, TigerConnect
Peter Stetson is the CMIO of TigerConnect. It’s now calling itself an AI platform to connect people, especially workflows between doctors, nurses, EMTs and devices. Until recently he was CMIO…
“The #1 longevity hack is ‘don’t be poor’” — Kara Swisher is a health economist
In full transparency, I’ve been a fangirl of Kara Swisher since I first read her work with Walt Mossberg and Recode, coinciding with my own work on the early adoption…